申请人:Hoffmann-La Roche Inc.
公开号:US08344027B2
公开(公告)日:2013-01-01
This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula
wherein A1, A2, R1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors.
本发明涉及一种新型4-二甲氨基丁酸衍生物,其化学式为A1,A2,R1,m和n在说明书和权利要求中定义,以及其药学上可接受的盐。这些化合物抑制肉碱棕榈酰转移酶(CPT)活性,特别是CPT2活性,并可用作药物治疗CPT2抑制剂调节的疾病的方法。